BD announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY investigational device exemption (IDE) ...

BD (NYSE: BDX) today announced that it completed enrollment in the iliac artery patient cohort in its pivotal AGILITY study.

A bioadaptor implant adaptable to vessel physiology was linked to less target lesion failure and target vessel failure ...

Becton Dickinson (BDX) announced full enrollment of the iliac artery patient cohort in its AGILITY investigational device ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY Investigational Device ...

One question, in light of FREEDOM, is how well new DES compare with CABG in patients with diabetes and multivessel disease.

Background: A primary aortoenteric fistula (AEF) is a pathologic communication between the aorta and the gastrointestinal tract. Although uncommon, this condition carries a substantial risk of ...

BUFFALO, N.Y. – Each year, more than 100,000 patients who have experienced a stroke or a transient ischemic attack (TIA), also known as a “mini-stroke,” undergo a carotid artery stenting procedure to ...

BUFFALO, N.Y. – Each year, more than 100,000 patients who have experienced a stroke or a transient ischemic attack (TIA), also known as a “mini-stroke,” undergo a carotid artery stenting procedure to ...

The Minima Stent System is the first stent designed, tested, and Food and Drug Administration–approved for use in neonates, infants, and children. Our objective was to evaluate the safety and efficacy ...